Skip to Main Content

Paper Details

Erratum to "Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/G and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib" [Lung Cancer, 108 (June 2017) 228-231].
Lung Cancer
4
2019
Author NameAffiliation
Vincent A MillerFoundation Medicine Inc
Siraj M AliFoundation Medicine Inc
  • 1 - 2

Datasets

Release 1.2